Reviews citing this publication (3)
- Treatment of Infections by OXA-48-Producing Enterobacteriaceae. Stewart A, Harris P, Henderson A, Paterson D. Antimicrob Agents Chemother 62 e01195-18 (2018)
- β-Lactam antibiotic targets and resistance mechanisms: from covalent inhibitors to substrates. Mora-Ochomogo M, Lohans CT. RSC Med Chem 12 1623-1639 (2021)
- Antimicrobial Resistance Conferred by OXA-48 β-Lactamases: Towards a Detailed Mechanistic Understanding. Hirvonen VHA, Spencer J, van der Kamp MW. Antimicrob Agents Chemother 65 e00184-21 (2021)
Articles citing this publication (18)
- OXA-48-Mediated Ceftazidime-Avibactam Resistance Is Associated with Evolutionary Trade-Offs. Fröhlich C, Sørum V, Thomassen AM, Johnsen PJ, Leiros HS, Samuelsen Ø. mSphere 4 e00024-19 (2019)
- Structural Insights into the Mechanism of Carbapenemase Activity of the OXA-48 β-Lactamase. Smith CA, Stewart NK, Toth M, Vakulenko SB. Antimicrob Agents Chemother 63 e01202-19 (2019)
- Identifying Oxacillinase-48 Carbapenemase Inhibitors Using DNA-Encoded Chemical Libraries. Taylor DM, Anglin J, Park S, Ucisik MN, Faver JC, Simmons N, Jin Z, Palaniappan M, Nyshadham P, Li F, Campbell J, Hu L, Sankaran B, Prasad BVV, Huang H, Matzuk MM, Palzkill T. ACS Infect Dis 6 1214-1227 (2020)
- Analysis of β-lactone formation by clinically observed carbapenemases informs on a novel antibiotic resistance mechanism. Aertker KMJ, Chan HTH, Lohans CT, Schofield CJ. J Biol Chem 295 16604-16613 (2020)
- Cryptic β-Lactamase Evolution Is Driven by Low β-Lactam Concentrations. Fröhlich C, Gama JA, Harms K, Hirvonen VHA, Lund BA, van der Kamp MW, Johnsen PJ, Samuelsen Ø, Leiros HS. mSphere 6 e00108-21 (2021)
- Mechanistic Basis of OXA-48-like β-Lactamases' Hydrolysis of Carbapenems. Stojanoski V, Hu L, Sankaran B, Wang F, Tao P, Prasad BVV, Palzkill T. ACS Infect Dis 7 445-460 (2021)
- Heteroaryl Phosphonates as Noncovalent Inhibitors of Both Serine- and Metallocarbapenemases. Pemberton OA, Jaishankar P, Akhtar A, Adams JL, Shaw LN, Renslo AR, Chen Y. J Med Chem 62 8480-8496 (2019)
- 19 F NMR Monitoring of Reversible Protein Post-Translational Modifications: Class D β-Lactamase Carbamylation and Inhibition. van Groesen E, Lohans CT, Brem J, Aertker KMJ, Claridge TDW, Schofield CJ. Chemistry 25 11837-11841 (2019)
- Structural insights into the enhanced carbapenemase efficiency of OXA-655 compared to OXA-10. Leiros HS, Thomassen AM, Samuelsen Ø, Flach CF, Kotsakis SD, Larsson DGJ. FEBS Open Bio 10 1821-1832 (2020)
- Structural Analysis of The OXA-48 Carbapenemase Bound to A "Poor" Carbapenem Substrate, Doripenem. Papp-Wallace KM, Kumar V, Zeiser ET, Becka SA, van den Akker F. Antibiotics (Basel) 8 E145 (2019)
- C6 Hydroxymethyl-Substituted Carbapenem MA-1-206 Inhibits the Major Acinetobacter baumannii Carbapenemase OXA-23 by Impeding Deacylation. Stewart NK, Toth M, Alqurafi MA, Chai W, Nguyen TQ, Quan P, Lee M, Buynak JD, Smith CA, Vakulenko SB. mBio 13 e0036722 (2022)
- Label-Free Visualization of Carbapenemase Activity in Living Bacteria. Zhang Y, Lei JE, He Y, Yang J, Wang W, Wasey A, Xu J, Lin Y, Fan H, Jing G, Zhang C, Jin Y. Angew Chem Int Ed Engl 57 17120-17124 (2018)
- Biochemical and biophysical characterization of the OXA-48-like carbapenemase OXA-436. Lund BA, Thomassen AM, Carlsen TJW, Leiros HKS. Acta Crystallogr F Struct Biol Commun 77 312-318 (2021)
- Discovery of Novel Chemical Series of OXA-48 β-Lactamase Inhibitors by High-Throughput Screening. Garofalo B, Prati F, Buonfiglio R, Coletta I, D'Atanasio N, Molteni A, Carettoni D, Wanke V, Pochetti G, Montanari R, Capelli D, Milanese C, Di Giorgio FP, Ombrato R. Pharmaceuticals (Basel) 14 612 (2021)
- Multiscale Simulations Identify Origins of Differential Carbapenem Hydrolysis by the OXA-48 β-Lactamase. Hirvonen VHA, Weizmann TM, Mulholland AJ, Spencer J, van der Kamp MW. ACS Catal 12 4534-4544 (2022)
- Unique Diacidic Fragments Inhibit the OXA-48 Carbapenemase and Enhance the Killing of Escherichia coli Producing OXA-48. Taylor DM, Anglin J, Hu L, Wang L, Sankaran B, Wang J, Matzuk MM, Prasad BVV, Palzkill T. ACS Infect Dis 7 3345-3354 (2021)
- An Ion-Pair Induced Intermediate Complex Captured in Class D Carbapenemase Reveals Chloride Ion as a Janus Effector Modulating Activity. Zhou Q, Catalán P, Bell H, Baumann P, Cooke R, Evans R, Yang J, Zhang Z, Zappalà D, Zhang Y, Blackburn GM, He Y, Jin Y. ACS Cent Sci 9 2339-2349 (2023)
- Discovery of Quercetin and Its Analogs as Potent OXA-48 Beta-Lactamase Inhibitors. Zhang Y, Chen C, Cheng B, Gao L, Qin C, Zhang L, Zhang X, Wang J, Wan Y. Front Pharmacol 13 926104 (2022)